INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2012

Patients with breast cancer showed impaired VO2peak across survivorship, and higher VO2peak was linked to lower risk of death in metastatic disease.

Cardiopulmonary exercise testing was used to evaluate VO2peak across four breast cancer cohorts totaling 248 women. Mean VO2peak was 17.8 ± 4.3 mL · kg(-1) · min(-1) (27% ± 17% below age-matched healthy sedentary women), and 32% had a VO2peak under 15.4 mL · kg(-1) · min(-1). VO2peak differed significantly across cohorts and was lowest in metastatic disease. In patients with metastatic disease (n = 52), achieving a VO2peak > 1.09 L · min(-1) was linked to an adjusted hazard ratio for death of 0.32 (95% CI, 0.16 to 0.67, P = .002) compared with a VO2peak ≤ 1.09 L · min(-1).

Shows an association, not proof of cause and effect.

Study type
Cross-sectional and prospective cohort study
Who was studied
248 women (age 55 ± 8 years) across four breast cancer cohorts
What was measured
Peak oxygen consumption (VO2peak) and risk of death in metastatic disease

THE PAPER

Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.

Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE, Douglas PS, Haykowsky M. J Clin Oncol, 2012.

PubMed 22614980 ↗DOI 10.1200/jco.2011.39.9014 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.